This most current twist while in the Lykos Therapeutics saga threatens An important overhaul of the corporate’s tactic and course, with Musk ally and billionaire investor Antonio Gracias showing to need to take the corporation back again toward its nonprofit drug advancement roots and a more Doblinite philosophy., James writes about why so Many i